ArticleCurrent medical science2018
Efficacy and Safety of Generic Dasatinib as a Second-line Treatment for Patients with Chronic Myeloid Leukemia: a Multicenter Retrospective Study in Hubei Province, China.
Li-Feng Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.